| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,373 | 7,952 | 7,415 | 7,689 | | Cost of Revenue | 2,488 | 2,575 | 2,698 | 2,773 | | | Gross Profit |
-
| 5,377 | 4,717 | 4,916 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,171 | 3,143 | 2,935 | 3,697 | | Non Recurring |
-
| (153) | 153 | 1,049 | | Others | (101) | 1,890 | 520 | (122) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 497 | 1,109 | 292 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,394) | 497 | 1,109 | 292 | | Interest Expense | 478 | 609 | 749 | 854 | | Income Before Tax | (1,872) | (112) | 360 | (562) | | Income Tax Expense | (821) | (17) | 98 | (6,026) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,485) | (95) | 261 | 5,464 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,051) | (95) | 261 | 5,464 | | Preferred Stock And Other Adjustments | (161) | (161) | (109) |
-
| | | Net Income Applicable To Common Shares | ($1,211) | ($256) | $152 | $5,464 |
|
0.01% Nasdaq 0.00%
Income Statement
